SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1619)6/5/2003 9:31:13 PM
From: Icebrg  Read Replies (2) | Respond to of 3044
 
Miljenko

>> I am one who believes in deep, broad, basic science. Without it there is no new breaktrue drugs. Unless you are lucky. And, MLNM was lucky with Velcade.>>

Yes, they were lucky to get Velcade. Because that was not at all what they bought. But they have managed the clinical development and regulatory work in an excellent way. That experience should be worth something going forward.

Erik



To: Miljenko Zuanic who wrote (1619)6/5/2003 9:35:52 PM
From: SemiBull  Respond to of 3044
 
.... Or MLNM is for sale, down the road?

I am absolutely not intending to bring speculation to this topic, but this was my visceral response to today's PR.



To: Miljenko Zuanic who wrote (1619)6/8/2003 1:24:36 AM
From: Madharry  Respond to of 3044
 
a profitable company


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News